Aayush Wellness launches Lung Care Tablets targeting ₹18,913 crore market

scanx
Reviewed by
Naman SScanX News Team
Key Highlights
  • Aayush Wellness launches Lung Care Tablets on August 29, 2026
  • Product targets smokers and those with respiratory issues
  • Enters a ₹18,913 crore respiratory healthcare market
  • Segment grew 10% YoY to ₹18,912.64 crore in 2025
powered bylight_fuzz_icon
49531555

*this image is generated using AI for illustrative purposes only.

Mumbai, August 29, 2026 — Aayush Wellness launched Lung Care Tablets on August 29, 2026, entering the ₹18,913 crore respiratory healthcare market. The product targets smokers and individuals with respiratory issues.

The company disclosed the launch under Regulation 30 of SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015. Managing Director Naveenakumar Kunjaru stated the move aligns with the firm’s prevention-led vision, building on the success of Aayush Herbal Masala.

Market Context

India’s respiratory healthcare segment recorded sales of ₹18,912.64 crore in 2025, up from ₹17,199.40 crore in 2024. This represents approximately 10% year-on-year growth. The company noted that India accounts for 30.28% of global deaths from respiratory diseases.

Metric 2025 2024 Change
Respiratory Segment Sales ₹18,912.64 crore ₹17,199.40 crore ~10%

Product Formulation

Lung Care Tablets combine herbal and nutritional ingredients, including N-Acetyl Cysteine (NAC), Vasaka Extract, Licorice, Quercetin, Vitamin C, Vitamin D2, and Zinc. The formulation aims to support:

  • Respiratory wellness and lung function
  • Healthy airway function
  • Antioxidant and immune support
  • Healthy inflammatory response
  • Overall lung-health maintenance

What the Numbers Show

The 10% growth in the respiratory segment sales from ₹17,199.40 crore in 2024 to ₹18,912.64 crore in 2025 indicates consistent expansion in this therapeutic category. This growth trajectory supports the company’s strategic entry into a market where India holds a significant share of global disease burden.

Strategic Outlook

Aayush Wellness positions the new tablets as a daily wellness solution to complement its existing preventive-health products. The company aims to increase product depth and create cross-selling opportunities across its customer base by addressing rising health concerns with targeted solutions.

Historical Stock Returns for Aayush Wellness

1 Day5 Days1 Month6 Months1 Year5 Years
+11.65%+23.76%+17.29%-12.32%-70.49%+1,223.67%

How might Aayush Wellness' entry into the respiratory segment impact the market share of established pharmaceutical competitors in the ₹18,913 crore space?

What regulatory hurdles or clinical validation requirements could affect the long-term scalability of Lung Care Tablets given their herbal and nutritional formulation?

Will Aayush Wellness leverage its existing distribution network for Aayush Herbal Masala to accelerate the penetration of Lung Care Tablets in rural markets?

Aayush Wellness shareholders approve new auditor and director appointments

scanx
Reviewed by
Riya DScanX News Team
Key Highlights

Aayush Wellness Limited shareholders approved the appointment of A. Ragnavendra Rao & Associates as statutory auditors and regularized the board appointments of Dinesh Dhangare and Kashiram Jadhav. The postal ballot concluded on August 17, 2026, with all three ordinary resolutions passing with approval rates exceeding 99%. Voting was driven by public non-institutional investors, with promoters abstaining from casting votes.

powered bylight_fuzz_icon
48662920

*this image is generated using AI for illustrative purposes only.

Shareholders of Aayush Wellness Limited have approved three ordinary resolutions concerning key governance changes, including the appointment of a new statutory auditor and the regularization of board member appointments. The voting process, conducted via remote e-voting and postal ballot forms, concluded on August 17, 2026.

The company disclosed the results in compliance with Regulation 44 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The resolutions were scrutinized by M/s. Aarju Agrawal & Associates, Practicing Company Secretaries, who confirmed that all proposals passed with the requisite majority.

Key Resolutions Passed

The postal ballot notice, issued on July 14, 2026, sought shareholder approval for three specific items. All three resolutions were classified as ordinary resolutions, with no promoter or promoter group interest declared in any of the agenda items.

Appointment of Statutory Auditors

The first resolution concerned the appointment of M/s. A. Ragnavendra Rao & Associates, Chartered Accountants, as the company’s statutory auditors. This appointment aims to fill the casual vacancy caused by the resignation of M/s. A.L.M.S & Co. LLP, Chartered Accountants.

Regularization of Director Appointments

The second and third resolutions sought to regularize the appointments of two individuals as Non-Executive Non-Independent Directors:

  • Mr. Dinesh Dhangare (DIN: 11418438)
  • Mr. Kashiram Jadhav (DIN: 11640980)

Voting Results Breakdown

The voting participation was driven primarily by public non-institutional investors, as promoters and institutional investors did not cast votes in this ballot. The total number of shares held eligible for voting stood at 48,671,699.

Resolution Total Votes Polled Votes in Favour Votes Against Approval Rate
Appointment of Statutory Auditors 2,375,924 2,374,403 1,521 99.94%
Appointment of Mr. Dinesh Dhangare 2,375,439 2,366,880 8,559 99.64%
Appointment of Mr. Kashiram Jadhav 2,375,629 2,365,502 10,127 99.57%

What the Numbers Show

The voting data reveals a distinct divergence between e-voting and postal ballot participation patterns. While e-voting saw significant opposition for the director appointments—with rejection rates of 7.78% for Mr. Dhangare and 9.19% for Mr. Jadhav—the postal ballot forms showed unanimous support. All 2,265,387 votes cast via postal ballot were in favor of every resolution. This suggests that while retail or smaller institutional voters using the digital platform expressed dissent, the block represented by physical ballot submissions supported the management’s proposals entirely.

Scrutinizer’s Report Details

M/s. Aarju Agrawal & Associates served as the scrutinizer for the process. The remote e-voting facility was provided by Central Depository Services (India) Limited (CDSL). The voting window opened on July 19, 2026, at 9:00 am and closed on August 17, 2026, at 5:00 pm. The scrutinizer unblocked the e-voting data on August 17, 2026, at 9:21 pm in the presence of two independent witnesses.

No invalid votes were recorded for any of the three resolutions. The complete list of members who voted for or against each resolution has been handed over to the company for safekeeping.

Historical Stock Returns for Aayush Wellness

1 Day5 Days1 Month6 Months1 Year5 Years
+11.65%+23.76%+17.29%-12.32%-70.49%+1,223.67%

How might the significant opposition to the director appointments via e-voting signal potential governance challenges or shareholder activism in future AGMs?

What strategic rationale does Aayush Wellness provide for replacing M/s. A.L.M.S & Co. LLP with M/s. A. Ragnavendra Rao & Associates as statutory auditors?

Will the regularization of Mr. Dinesh Dhangare and Mr. Kashiram Jadhav lead to any immediate changes in the company's operational strategy or board composition?

More News on Aayush Wellness

1 Year Returns:-70.49%